Skip to main content
OpenTrials
Completed

NCT Number: NCT02664285

Closure Versus Non Closure of Subcutaneous Tissue After Cesarean Section in Diabetic Patients

The aim of this study is to determine the surgical site infection rate and the patient's satisfaction for closure of subcutaneous tissue versus non closure of subcutaneous tissue after cesarean delivery in women with diabetes mellitus.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–45 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

About this study

This is a randomized prospective comparative clinical study will be conducted in Ain Shams University, Maternity Hospital.

This study will include a sample of (136) pregnant women with gestational diabetes mellitus and type 2 diabetes mellitus who underwent elective Cesarean section.

Patients will b divided into two groups:

Group A (closure group): will include 68 pregnant women who underwent elective Cesarean section with closure of subcutaneous tissue. Group B (non closure group): will include 68 pregnant women who underwent elective Cesarean section without closure of subcutaneous tissue.

  • All participants in the study will have consent.

All included women will be subjected to the following:

  • History Full history taking, (personal, present, past and obstetrics history).
  • Clinical examination including:

General examination:

  • Assessment of vital data
  • Assessment of general condition.
  • Cardiac and chest examination, to exclude any contraindication for anesthesia.

Abdominal examination:

Assessment of fundal level for fetal dating, fetal lie and fetal heart sound. 3. Investigations: Laboratory Complete blood picture.- Random blood sugar.

Ultrasonography:

Fetal biometry for fetal dating and fetal viability. 4. All participants operated under general or spinal anesthesia. Prophylactic antibiotic is given according to the approved protocol of Ain Shams Maternity Hospital (as two intravenous doses of broad spectrum penicillin (after clamping of the umbilical cord and 12 hours postoperatively. Oral antibiotic of the same group was then started for 3-5 days.

5.In group A (closure group)the subcutaneous fat will be closed with three to five interrupted sutures. The sutures were tied until the tissue was adequately re-approximated, but not as hard as possible to avoid necrosis. In group B (non closure group) the subcutaneous fat will not sutured.

6.In all participants Skin to be closed by subcuticular stitches using absorbable polyglactin 910 suture 7. Dressing is removed after 48hours postoperatively, to be disinfected with alcohol 70% antiseptic solution daily in both groups.

  • The wound is to be inspected 48 hours, 7 days and one month after the cesarean section.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Pregnant women in childbearing period (18-45 years).
  • Women planned for elective cesarean section.
  • Pregnant women with gestational diabetes according to medical records.

Exclusion criteria

  • Hemoglobin less than 10g/dl.
  • Intra operative events that may themselves predispose to postoperative infection (e.g. operative time more than 90 minutes).
  • Rupture of membrane more than 12 hours.
  • Receive corticosteroid medications.
  • Immunosuppressive disease or Auto immune disease.
  • Concurrent infection (e.g. signs of pyelonephritis, chest infection).
  • Previous history of two C.S.
  • Previous laparotomy other than C.S.

Treatment and study plan

closure of subcutaneous tissue

Other

the subcutaneous fat will be closed with three to five interrupted sutures. The sutures were tied until the tissue was adequately re-approximated, but not as hard as possible to avoid necrosis after cesarean section in diabetic patients.

No closure of subcutaneous tissue

Other

the subcutaneous fat will not sutured after cesarean section in diabetic patients.

Primary outcomes

  1. Number of participants with surgical site infection

    Time frame: 9 months

    Surgical site infection: including the following manifestations: Collection; inflammatory signs (pain, tenderness, edema, redness); dehiscence (wound separation) or positive culture.

Secondary outcomes

  1. Number of participants with wound seroma

    Time frame: month

    wound seroma, superficial wound breakdown (defined as skin and/or subcutaneous dehiscence with intact fascial layer).

  2. Number of participants with postoperative pain

    Time frame: 24 hours

    Postoperative pain (judged after 24 hours, through visual analogue scale (VAS); with 0 meaning no pain, and 10 meaning the worst pain).

  3. Number of participants with postoperative fever

    Time frame: 48 hours

    postoperative fever (defined as temperature more than thirty eight degree, 48 hours postoperative.

  4. Number of participants with cosmetic wound

    Time frame: 1 month

    Is cosmetic wound outcome for one month postoperative good or no?

Sponsors and collaborators

Lead sponsor

Ain Shams University

Other

Registry information

Important dates

Study start
2016
Primary completion
2016
Study completion
2016
First posted
Jan 27, 2016
Registry last updated
Nov 8, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.